NCT02614222

Brief Summary

The objective of this research is to determine if the addition of the Clear Guide ONE, a Computer Assisted Instrument Guidance (CAIG) system, provides improvement over existing ultrasound guided, needle-based procedures for peripheral nerve blocks. The ultrasound can visualize the targeted vessel or nerve, but the addition of the CAIG may help the clinician better guide the needle to the target.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 26, 2015

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

November 19, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 25, 2015

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2016

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

June 14, 2017

Completed
Last Updated

July 7, 2017

Status Verified

June 1, 2017

Enrollment Period

7 months

First QC Date

November 19, 2015

Results QC Date

January 30, 2017

Last Update Submit

June 12, 2017

Conditions

Keywords

Computer Assisted Instrument Guidance (CAIG)Peripheral Nerve BlockClear Guide ONENeedle pathNeedle GuidanceUltrasound

Outcome Measures

Primary Outcomes (1)

  • Time Needed to Correctly Identify the Neural Structure(s) and Induce the Peripheral Nerve Block

    Immediately after intervention (within 2 hours)

Secondary Outcomes (7)

  • Clinician Rating of the Device

    Immediately following intervention (within 2 hours)

  • Number of Attempts

    Immediately following intervention (within 2 hours)

  • Number of Times Needle Needs Repositioning

    Immediately following intervention (within 2 hours)

  • Patient Satisfaction Recorded on Post-op Day 1 Using Questionnaire

    Post-op day 1

  • Number of Patients That Needed Rescue Opioids

    During hospital stay (maximum 3 days)

  • +2 more secondary outcomes

Study Arms (2)

Peripheral Nerve Block with CAIG

EXPERIMENTAL

The participants in this group (test group) will utilize the same procedure utilizing existing ultrasound equipment with the supplemental CAIG system.

Device: Peripheral Nerve Blocks with CAIG

Peripheral Nerve Block without CAIG

NO INTERVENTION

The participants in the control group will receive the procedure with traditional ultrasound methods and equipment.

Interventions

The Clear Guide ONE is a Computer Assisted Instrument Guidance (CAIG) device which supplements existing ultrasound capabilities. The participants randomly selected (out of 100 patients) for use of the Clear Guide ONE (test group) will receive ultrasound guidance as well as CAIG from the MDs performing the procedure.

Also known as: Clear Guide ONE
Peripheral Nerve Block with CAIG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing orthopedic surgery who are candidates for peripheral nerve blocks for control of postoperative pain
  • Able to give written informed consent

You may not qualify if:

  • Unable to give informed consent
  • Patients in whom regional anesthesia is contradicted

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Cooper Health System

Camden, New Jersey, 08103, United States

Location

Results Point of Contact

Title
Dr. Ronak Desai
Organization
The Cooper Health System

Study Officials

  • Ronak Desai, DO

    The Cooper Health System

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2015

First Posted

November 25, 2015

Study Start

October 26, 2015

Primary Completion

May 25, 2016

Study Completion

May 25, 2016

Last Updated

July 7, 2017

Results First Posted

June 14, 2017

Record last verified: 2017-06

Locations